We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$33.9B
AUM Growth
-$1.05B
Cap. Flow
-$1.27B
Cap. Flow %
-3.76%
Top 10 Hldgs %
9.76%
Holding
1,528
New
93
Increased
461
Reduced
505
Closed
116

Top Buys

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$50.1M
2
GCO icon
Genesco
GCO
+$46.4M
3
DAN icon
Dana Inc
DAN
+$41.3M
4
KW
Kennedy-Wilson Holdings
KW
+$31.1M
5
JBTM
JBT Marel
JBTM
+$30.8M

Sector Composition

Rank Sector Weight
1 Industrials 23.38%
2 Technology 16.32%
3 Consumer Discretionary 13.09%
4 Financials 9.81%
5 Materials 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGS icon
476
Natural Gas Services Group
NGS
$460M
$16.7M 0.05%
554,766
+4,103
+0.7% +$122K
GPX
477
DELISTED
GP Strategies Corp.
GPX
$16.7M 0.05%
613,865
-33,200
-5% -$939K
NTRS icon
478
Northern Trust
NTRS
$22.2B
$16.7M 0.05%
254,348
+4,000
+2% +$248K
BKU icon
479
Bankunited
BKU
$3.41B
$16.7M 0.05%
479,498
-23,500
-5% -$768K
TTC icon
480
Toro Company
TTC
$9.08B
$16.7M 0.05%
527,528
-685,372
-57% -$22M
PAG icon
481
Penske Automotive Group
PAG
$14.5B
$16.6M 0.05%
389,200
LMIA
482
DELISTED
LMI Aerospace Inc
LMIA
$16.6M 0.05%
1,176,091
+120,190
+11% +$1.72M
SRDX
483
DELISTED
Surmodics
SRDX
$16.6M 0.05%
733,300
CHRW icon
484
C.H. Robinson
CHRW
$20B
$16.6M 0.05%
316,000
+60,000
+23% +$3.27M
ROCK icon
485
Gibraltar Industries
ROCK
$1.39B
$16.5M 0.05%
873,945
+95,707
+12% +$1.74M
IRDM icon
486
Iridium Communications
IRDM
$4.81B
$16.4M 0.05%
2,188,989
+406,883
+23% +$2.72M
LPX icon
487
Louisiana-Pacific
LPX
$5.35B
$16.3M 0.05%
966,100
+482,100
+100% +$8.46M
KAI icon
488
Kadant
KAI
$3.72B
$16.3M 0.05%
445,847
BMI icon
489
Badger Meter
BMI
$3.9B
$16.2M 0.05%
589,028
SEM
490
DELISTED
Select Medical
SEM
$16.2M 0.05%
2,418,580
-185,600
-7% -$1.13M
GHM icon
491
Graham Corp
GHM
$1.17B
$16.1M 0.05%
505,827
-22,558
-4% -$791K
CBST
492
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$16.1M 0.05%
219,900
-87,900
-29% -$6.55M
SFY
493
DELISTED
SWIFT ENERGY CO (HOLDING COMPANY)
SFY
$16.1M 0.05%
1,491,851
+230,000
+18% +$2.69M
PIPR icon
494
Piper Sandler
PIPR
$5.24B
$16M 0.05%
1,397,148
-706,052
-34% -$7.18M
MENT
495
DELISTED
Mentor Graphics Corp
MENT
$15.9M 0.05%
722,203
+42,900
+6% +$932K
CINF icon
496
Cincinnati Financial
CINF
$28.3B
$15.9M 0.05%
326,700
HUBG icon
497
HUB Group
HUBG
$2.92B
$15.9M 0.05%
793,800
MVC
498
DELISTED
MVC Capital, Inc.
MVC
$15.6M 0.05%
1,153,700
ALX
499
Alexander's
ALX
$1.36B
$15.6M 0.05%
+43,262
New +$15M
DAKT icon
500
Daktronics
DAKT
$953M
$15.5M 0.05%
1,078,523
+63,500
+6% +$912K

Similar funds

Royce & Associates's Q1 2014 Portfolio in Review

As of Q1 2014, Royce & Associates held 1,528 positions worth $33.9B, down 3% from $34.9B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Royce & Associates withdrew a net $1.27B in Q1 2014, closing 116 positions and reducing 505 holdings. Its most notable exit was ARDEN GROUP INC CL-A, an estimated $34.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Neenah, Inc. Common Stock worth $23.5M.

  • Royce & Associates's largest Q1 2014 buy was Neenah, Inc. Common Stock: 454,500 shares worth $23.5M.
  • Royce & Associates added most to Medicines Co in Q1 2014, an estimated $50.1M increase.
  • Royce & Associates's biggest Q1 2014 reduction was TOWERS WATSON & CO COM STK CL A (DE), cutting an estimated $87.3M.
  • Royce & Associates fully exited ARDEN GROUP INC CL-A in Q1 2014, selling an estimated $34.3M.
  • Royce & Associates's ten largest holdings make up 9.8% of its $33.9B portfolio in Q1 2014.
  • Royce & Associates opened 93 new positions and closed 116 in Q1 2014.
  • Royce & Associates's portfolio value fell 3% quarter-over-quarter to $33.9B.

Based on Royce & Associates's 13F filing for Q1 2014, filed 12 May 2014.